При пациенти, които на шестия месец от началото на лечението са негативни за НСV РНК, лечението трябва да продължи още 6 месеца (т. е. до обща продължителност 1 година). • Всички останали генотипове:
During those clinical trials in which patients were treated for one year, patients who failed to show a virological response after six months of treatment (HCV-RNA below lower limit of detection) were unlikely to become sustained virological responders (HCV-RNA below lower limit of detection six months after withdrawal of treatment). • Genotype 1: